Laboratory Services

 

Spire’s revenue surge hints at rising private sector opportunities delivering NHS services

On September 12, Spire Healthcare, one of the UK’s top for-profit private hospital groups, reported a rise in revenues and profits. The company stated that this surge was partly driven by increased NHS outsourcing and higher private insurance uptake among working-age individuals.  The hospital’s pre-tax profits rose approximately 12% to £23 million in the first half of the year, with revenues increasing about 13% to £763 million. Spire expects annual underlying profits to range between £255 million and £275 million, having already achieved £130.6 million in the first six months.

Brookfield Asset Management takeover of Grifols continues to progress with new debt financing move

The anticipated Brookfield Asset Management takeover of Catalonia’s Grifols has gathered fresh momentum, with the firm reportedly in talks with banks to secure approximately €9.5 billion in debt financing towards the deal, according to Bloomberg sources.  The Canadian investment firm is exploring the acquisition in partnership with the Grifols family, who hold a ~30% stake […]

How CRISPR and HiBiT can accelerate drug discovery

CRISPR has been called one of the most exciting developments in genetic engineering. It is opening up new possibilities in medicine, particularly for discovering new types of drugs for genetic diseases and new ways of repairing and replacing organs and tissue in regenerative medicine. In an interview with HBI, Philip Hargreaves, Director of Strategic Marketing & Business Development at Promega UK, the UK  branch of US biotech company Promega, spoke about how CRISPR, when combined with Promega’s innovative HiBiT technology, can accelerate the drug discovery process.

Exploring ‘dark labs’, at-home testing potential, and the diagnostic lab sector’s consolidation at HBI 2024

The global laboratory diagnostics market has grown significantly, with research estimating its value at around USD $210.58 billion in 2023. It is expected to reach approximately USD $284.38 billion by 2033, expanding at a CAGR of 3.05% from 2024 to 2033. This growth is driven by rising chronic diseases, an ageing population, and the increasing demand for early diagnostics. At HBI 2024, the panel 'Laboratory Diagnostics – Growth Beyond Consolidation' brought together industry experts.

Find Us